Agilent Technologies, Inc. which can be found using ticker (A) now have 17 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 163 and 110 with the average target price sitting at $139.31. Given that the stocks previous close was at $119.92 and the analysts are correct then we can expect a percentage increase in value of 16.2%. Also worth taking note is the 50 day moving average now sits at $121.90 and the 200 day MA is $136.41. The market cap for the company is 35.75B. The stock price is currently at: 122.02 USD
The potential market cap would be $41,532,616,432 based on the market consensus.
The company has a dividend yield of 2.35%. Other points of data to note are a P/E ratio of 31.94, revenue per share of 23.69 and a 8.7% return on assets.
Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.
